Alexandra Miller

3.2k total citations
48 papers, 641 citations indexed

About

Alexandra Miller is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Alexandra Miller has authored 48 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 14 papers in Pulmonary and Respiratory Medicine and 12 papers in Cancer Research. Recurrent topics in Alexandra Miller's work include Glioma Diagnosis and Treatment (19 papers), Cancer Genomics and Diagnostics (10 papers) and Brain Metastases and Treatment (7 papers). Alexandra Miller is often cited by papers focused on Glioma Diagnosis and Treatment (19 papers), Cancer Genomics and Diagnostics (10 papers) and Brain Metastases and Treatment (7 papers). Alexandra Miller collaborates with scholars based in United States, Switzerland and Canada. Alexandra Miller's co-authors include Charles A. Greer, Helen B. Treloar, Lisa M. DeAngelis, Vaios Hatzoglou, Caroline Miranda, Stuart Firestein, Lydia R. Maurer, Maria E. Arcila, Richard A. Hickman and Matthias A. Karajannis and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Blood.

In The Last Decade

Alexandra Miller

40 papers receiving 629 citations

Peers

Alexandra Miller
Ronald J. Beyers United States
Ruth Saunders United Kingdom
Ryan M. Mitchell United States
A. Elderson Netherlands
Alexandra Miller
Citations per year, relative to Alexandra Miller Alexandra Miller (= 1×) peers Francesca Del Gaudio

Countries citing papers authored by Alexandra Miller

Since Specialization
Citations

This map shows the geographic impact of Alexandra Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Miller more than expected).

Fields of papers citing papers by Alexandra Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Miller. The network helps show where Alexandra Miller may publish in the future.

Co-authorship network of co-authors of Alexandra Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Miller. A scholar is included among the top collaborators of Alexandra Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Miller. Alexandra Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Golfinos, John G., et al.. (2025). Ultra-rapid droplet digital PCR enables intraoperative tumor quantification. Med. 6(6). 100604–100604. 1 indexed citations
2.
Crotty, Erin, Sarah Leary, Alexandra Miller, et al.. (2025). Targeted detection of sequence variants in cell-free DNA from cerebrospinal fluid in pediatric central nervous system tumors. Frontiers in Oncology. 14. 1513073–1513073.
4.
Mikolajewicz, Nicholas, Patricia Yee, Alexandra Miller, et al.. (2024). Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application. Journal of Clinical Oncology. 42(16). 1961–1974. 13 indexed citations
5.
Hickman, Richard A., Alexandra Miller, & Maria E. Arcila. (2023). Cerebrospinal fluid: A unique source of circulating tumor DNA with broad clinical applications. Translational Oncology. 33. 101688–101688. 19 indexed citations
6.
Hickman, Richard A., Erika Gedvilaite, Ryan Ptashkin, et al.. (2023). CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas. Acta Neuropathologica. 146(6). 845–847. 12 indexed citations
7.
Rana, Satshil, Anne S. Reiner, Andrew Lin, et al.. (2023). Leptomeningeal disease in histone-mutant gliomas. Neuro-Oncology Advances. 5(1). vdad068–vdad068. 3 indexed citations
8.
Schaff, Lauren, Andrew Lin, Subhiksha Nandakumar, et al.. (2022). Combination Olaparib and Temozolomide for the Treatment of Glioma. Neurology. 99(17). 750–755. 7 indexed citations
9.
Lin, Andrew, Alexandra Miller, Igor T. Gavrilovic, et al.. (2022). Concurrent Olaparib and Temozolomide for Recurrent Glioma (P5-9.005). Neurology. 98(18_supplement).
10.
Wijetunga, N. Ari, Alexander G. Goglia, Nils Weinhold, et al.. (2022). Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases. Clinical Cancer Research. 29(4). 775–783. 5 indexed citations
11.
Schaff, Lauren, Dean Carlow, Ryan Schofield, et al.. (2022). Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study. BMC Cancer. 22(1). 60–60. 8 indexed citations
12.
Coffee, Elizabeth, Thomas Kaley, Eli L. Diamond, Alexandra Miller, & Lauren Schaff. (2022). BRAFV600E-mutant glioblastoma responds to combination BRAF/MEK inhibition with encorafenib and binimetinib (P5-9.007). Neurology. 98(18_supplement).
13.
Govindarajan, Raghav, Rachel Marie E. Salas, Alexandra Miller, et al.. (2021). Accelerated Implementation of a Virtual Neurology Clerkship Amid a Global Crisis. Neurology. 98(7). 279–286. 6 indexed citations
14.
Young, Robert J., Paula Demétrio De Souza França, Giacomo Pirovano, et al.. (2020). Preclinical and first-in-human-brain-cancer applications of [18F]poly (ADP-ribose) polymerase inhibitor PET/MR. Neuro-Oncology Advances. 2(1). vdaa119–vdaa119. 26 indexed citations
15.
Diamond, Eli L., Holly G. Prigerson, Anne S. Reiner, et al.. (2017). Prognostic awareness, prognostic communication, and cognitive function in patients with malignant glioma. Neuro-Oncology. 19(11). 1532–1541. 54 indexed citations
16.
Sood, Anup, Alexandra Miller, Edi Brogi, et al.. (2016). Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolism. JCI Insight. 1(6). 35 indexed citations
17.
Miller, Alexandra, Hoa T. Vo, Liang Huo, et al.. (2010). Estrogen receptor alpha (ESR-1) associations with psychological traits in women with PMDD and controls. Journal of Psychiatric Research. 44(12). 788–794. 34 indexed citations
18.
Rodriguez‐Gil, Diego J., Helen B. Treloar, Xiaohong Zhang, et al.. (2010). Chromosomal Location-Dependent Nonstochastic Onset of Odor Receptor Expression. Journal of Neuroscience. 30(30). 10067–10075. 38 indexed citations
19.
Rodriguez‐Gil, Diego J., et al.. (2009). Onset of Odorant Receptors. Annals of the New York Academy of Sciences. 1170(1). 18–20. 5 indexed citations
20.
Velı́šková, Jana, Alexandra Miller, Magda Lahorgue Nunes, & Lucy L. Brown. (2005). Regional neural activity within the substantia nigra during peri-ictal flurothyl generalized seizure stages. Neurobiology of Disease. 20(3). 752–759. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026